SCHEMBL6198528

SCHEMBL6198528

CCCc1cc(C(=O)O)cc(-c2csc(-c3ccc(OCC)c(OCC)c3)n2)c1O

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.57
PDE4B Q07343 1/20 0.57
PDE4C Q08493 1/20 0.57
PDE4D Q08499 1/20 0.57
SREBF2 Q12772 8/20 0.44
EIF4E P06730 3/20 0.44
MAPT P10636 2/20 0.42
THRB P10828 1/20 0.42
ALDH1A1 P00352 4/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 4/20 0.41
NPC1 O15118 2/20 0.41
HPGD P15428 1/20 0.41
S1PR1 P21453 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6197840 0.88 PDE4A (0.55) PDE4APDE4BPDE4CPDE4DEIF4E
Hydrochloric Acid SCHEMBL6201928 0.86 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DEIF4E
SCHEMBL6198983 0.85 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL6201414 0.83 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL6198628 0.82 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL6196583 0.81 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL6200825 0.80 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DSREBF2
SCHEMBL6200009 0.79 PDE4A (0.56) PDE4APDE4BPDE4CPDE4DEIF4E
SCHEMBL6198250 0.79 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DEIF4E
SCHEMBL4653511 0.79 PDE4A (0.61) PDE4APDE4BPDE4CPDE4DSREBF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed